COVID-19: Valneva begins clinical trials for new coronavirus vaccine in UK

Clinical trials have begun in the UK for a new COVID-19 vaccine being developed in Scotland. The UK government has pre-ordered 60 million doses of the Valneva candidate, which is being developed at the French biotech company's facility in Livingston, West Lothian. It is being tested on 150 volunteers at four National Institute for Health Research (NIHR) testing sites in Birmingham, Bristol, Newcastle and Southampton.